Causaly
Healthcare Software · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10 16 Elm St, London, Greater London, WC...Phone Number
+44 7538004312Website
www.causaly.comRevenue
$27.3 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
2
3
3
2
About Causaly
Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causalys unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development.Explore more
Causaly Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Causaly your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Causaly launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Causaly has recently received funding, and reach out quickly before it becomes old news!
Click to see if Causaly had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Causaly has new funding data
Earning: See what the market has to say on Causaly recently announced quarterly report
Causaly, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Causaly is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Causaly
Recommended Actions
Find VP level buyers at Causaly
Find 3 more new buyers
Compare Similar Companies to Causaly
Compare insights from companies similar to Causaly, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Causaly is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Causaly is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Causaly.
Causaly financials insights
Gather financial insights about Causaly, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$4.8M
2021
Unspecified
$17M
2023
Series B
$60M
Causaly Tech Stack
A closer look at the technologies used by Causaly
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Causaly News & Media
Causaly Introduces Scientific Workflows to Turn Expert Scientific Methods into Repeatable, AI-Executed Processes in Life Sciences
Causaly platform codifies biopharma R&D processes into end-to-end workflows that AI agents run consistently for any program, team, and therapeutic area LONDON, May 28, 2026 /PRNewswire/ -- Causaly today announced Scientific Workflows, a new solution in its agentic AI platform that turns...Causaly Introduces First Agentic AI Platform Built for Life Sciences Research and Development
Specialized AI agents automate research workflows and accelerate drug discovery and development with transparent, evidence-backed insights LONDON, Sept. 16, 2025 /PRNewswire/ -- Causaly today introduced Causaly Agentic Research, an agentic AI breakthrough that delivers the transparency...Causaly Announces Agentic AI for Scientific Discovery
New AI agents in Causaly Discover empower scientists to answer complex biomedical questions faster and more accurately across a broader range of sources LONDON, March 31, 2025 /PRNewswire/ -- Causaly today announced new scientific AI agents that provide research teams with the industry's...Causaly, an AI platform for drug discovery and biomedical research, raises $60M
Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery. Today, another hopeful in the space is announcing a funding round to expand its own contribution to the field. Causaly, a London startup that has built an AI platform to help researchers […] Causaly, an AI platform for drug discovery and biomedical research, raises $60M by Ingrid Lunden originally published on TechCrunch
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Causaly
Sign Up For FreeTo access detailed company insights
Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causalys unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development.... Read More
